MICHELLE TREVINO: Open Payments
NPI 1306507058 · LEHIGH ACRES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,437 in 85 payments from 13 companies in 2025. Trend: 2023 $1,537 · 2024 $1,865 · 2025 $1,437
Food & beverage: $1,437
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $297 |
| Axsome Therapeutics, Inc. | 9 | $182 |
| Supernus Pharmaceuticals, Inc. | 12 | $174 |
| Alkermes, Inc. | 8 | $156 |
| Neurocrine BioSciences, Inc. | 4 | $120 |
| Collegium Pharmaceutical, Inc. | 5 | $93 |
| E.R. Squibb & Sons, L.L.C. | 5 | $83 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| Almatica Pharma LLC | 3 | $58 |
Products named: CAPLYTA, Auvelity, Qelbree, ARISTADA, INGREZZA, Jornay PM, COBENFY, FANAPT.
Industry payments across FL — which companies pay providers there.
